Connection

YADOLLAH HARATI to Amyotrophic Lateral Sclerosis

This is a "connection" page, showing publications YADOLLAH HARATI has written about Amyotrophic Lateral Sclerosis.
  1. Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature. J Clin Neuromuscul Dis. 2012 Dec; 14(2):82-5.
    View in: PubMed
    Score: 0.360
  2. What's in the Literature? J Clin Neuromuscul Dis. 2009 Dec; 11(2):88-95.
    View in: PubMed
    Score: 0.292
  3. Motor unit number estimation, ALS and clinical trials. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar; 1(2):71-82.
    View in: PubMed
    Score: 0.149
  4. Novel valosin-containing protein mutations associated with multisystem proteinopathy. Neuromuscul Disord. 2018 06; 28(6):491-501.
    View in: PubMed
    Score: 0.130
  5. Longitudinal tracking of the same single motor unit in amyotrophic lateral sclerosis. Muscle Nerve. 1997 Apr; 20(4):511-3.
    View in: PubMed
    Score: 0.121
  6. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010 Dec; 11(6):542-8.
    View in: PubMed
    Score: 0.075
  7. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010 Nov; 32(9):913-22.
    View in: PubMed
    Score: 0.075
  8. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003 Sep 23; 61(6):742-9.
    View in: PubMed
    Score: 0.048
  9. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Jun; 4(2):62-73.
    View in: PubMed
    Score: 0.047
  10. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology. 2001 Aug 14; 57(3):500-4.
    View in: PubMed
    Score: 0.041
  11. Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II. Neurology. 1996 Oct; 47(4 Suppl 2):S86-90; discussion S90-2.
    View in: PubMed
    Score: 0.029
  12. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann Neurol. 1996 Feb; 39(2):203-16.
    View in: PubMed
    Score: 0.028
  13. Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease. Muscle Nerve. 1995 Jun; 18(6):620-7.
    View in: PubMed
    Score: 0.027
  14. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell. 2008 Jun 13; 133(6):963-77.
    View in: PubMed
    Score: 0.016
  15. A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis. Arch Neurol. 1988 Apr; 45(4):381-6.
    View in: PubMed
    Score: 0.016
  16. Sialosylglobotetraosylceramide: a marker for amyotropic lateral sclerosis. Biochem Biophys Res Commun. 1984 Jan 13; 118(1):82-9.
    View in: PubMed
    Score: 0.012
  17. Free amino acid levels in amyotrophic lateral sclerosis. Ann Neurol. 1978 Apr; 3(4):305-9.
    View in: PubMed
    Score: 0.008
  18. Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA. 1989 Jul 07; 262(1):53-6.
    View in: PubMed
    Score: 0.004
  19. Tubular aggregates: their association with myalgia. J Neurol Neurosurg Psychiatry. 1985 Sep; 48(9):882-6.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.